Table 1.
Baseline patient characteristics and operative data
| Characteristic | Value |
|---|---|
| Male | 32 (42.6%) |
| Female | 43 (57.3%) |
| Age* | 50.7±16.5 years |
| Right PCC | 39 |
| Left PCC | 40 |
| Tumor size* | 49±20 mm |
| Associated pathologies | 8 (10.6%) |
| MEN type 2 | 5 (6.6%) |
| Cardiopathy | 6 (8%) |
| Coronary disease | 4 (5.3%) |
| Pre-operative FEVG <45% | 0 (0%) |
| Recklinghausen disease | 3 (4%) |
| Morbid obesity | 2 (2.6%) |
| Beckwith Wiedermann syndrome | 1 (1.3%) |
| Chronic renal failure | 1 (1.3%) |
| Pre-operative hypertension (SAP >160 mmHg) | 0 (0%) |
| Duration of pneumoperitoneum* | 76.3±32 min |
| Urapidil infusion rate* | 42.4±30 mg/h |
| Sufentanyl total dose* | 114±40 μg |
| Median per-operative plasma levels of norepinephrine** (normal value <510 pg/ml) | 3216[1487-8645] pg/ml |
| Surgical approach | |
| Laparoscopic trans-peritoneal | 69 (87.3%) |
| Laparoscopic retro-peritoneal | 8 (10.1%) |
| Conversion to laparotomy | 2 (2.5%) |
| Average blood loss | 200 (150-340) ml |
*Mean±SD, **Median [interquartile range]. PCC=Pheochromocytoma; MEN: multiple endocrine neoplasia; SAP=Systolic arterial pressure